<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Jameshebrew - Latest News</title>
<link href="https://news.prbase.org/rss/jameshebrew/latest.xml"></link>
<updated>2026-08-31T13:03:20+00:00</updated>
<id>urn:uuid:05a9f158-0bd1-2190-0654-c78a08334acc</id>
<entry>
<title>Human Microbiome Market, 2019-2030 by Roots Analysis</title>
<link href="https://news.prbase.org/@jameshebrew/human-microbiome-market-2019-2030-by-roots-analysis-rnwqn3y4x7p3"></link>
<id>urn:uuid:c7b10a7f-f597-e96c-520c-42cb25da5d30</id>
<summary type="html"><![CDATA[Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future]]></summary>
<updated>2021-09-02T09:18:58+00:00</updated>
</entry>
<entry>
<title>Patient Recruitment and Retention Services Marker, 2019-2030 by Roots Analysis</title>
<link href="https://news.prbase.org/@jameshebrew/patient-recruitment-and-retention-services-marker-2019-2030-by-roots-analysis-jdp755wak7wr"></link>
<id>urn:uuid:68dff2be-0995-7702-5f02-43c812374303</id>
<summary type="html"><![CDATA[A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers]]></summary>
<updated>2021-09-02T07:21:08+00:00</updated>
</entry>
<entry>
<title>Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market By Rootsanalysis</title>
<link href="https://news.prbase.org/@jameshebrew/liquid-biopsy-and-other-non-invasive-cancer-diagnostics-market-by-rootsanalysis-jp67re6rrq5k"></link>
<id>urn:uuid:f38a6939-11ff-4e66-73c6-06dc89236728</id>
<summary type="html"><![CDATA[Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access]]></summary>
<updated>2021-08-31T05:51:32+00:00</updated>
</entry>
<entry>
<title>Drug Repurposing Service Providers Market, 2020-2030 By Roots Analysis</title>
<link href="https://news.prbase.org/@jameshebrew/drug-repurposing-service-providers-market-2020-2030-by-roots-analysis-rnwqn3nwk7p3"></link>
<id>urn:uuid:67c8e8db-390a-7700-b9cf-9b73b6acf951</id>
<summary type="html"><![CDATA[Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs]]></summary>
<updated>2021-08-31T04:29:39+00:00</updated>
</entry>
<entry>
<title>Elastomeric Closure Components Market For Vials, Cartridges and Syringes by Roots Analysis</title>
<link href="https://news.prbase.org/@jameshebrew/elastomeric-closure-components-market-for-vials-cartridges-and-syringes-by-roots-analysis-w3d7pwrajqk5"></link>
<id>urn:uuid:f8d854c1-7256-8c09-4c72-9274b6092c57</id>
<summary type="html"><![CDATA[Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential]]></summary>
<updated>2021-08-26T09:28:15+00:00</updated>
</entry>
<entry>
<title>Manufacturing Market Continuous by Roots Analysis</title>
<link href="https://news.prbase.org/@jameshebrew/manufacturing-market-continuous-by-roots-analysis-w3d7pwrmjqk5"></link>
<id>urn:uuid:f382df51-9cd3-2207-3b48-86df1d2879f0</id>
<summary type="html"><![CDATA[Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing]]></summary>
<updated>2021-08-26T07:08:26+00:00</updated>
</entry>
<entry>
<title>The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030</title>
<link href="https://news.prbase.org/@jameshebrew/the-biopharmaceutical-contract-biomanufacturing-market-is-projected-to-be-worth-usd-324-billion-by-2030-mp3q3rr6n7ne"></link>
<id>urn:uuid:3bb226dc-6201-2137-c93a-1b596d9931c8</id>
<summary type="html"><![CDATA[Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs]]></summary>
<updated>2021-08-13T08:50:41+00:00</updated>
</entry>
<entry>
<title>The CAR-T therapies market is characterized by a healthy pipeline of promising therapies</title>
<link href="https://news.prbase.org/@jameshebrew/the-car-t-therapies-market-is-characterized-by-a-healthy-pipeline-of-promising-therapies-5x8qewww8qdj"></link>
<id>urn:uuid:70863abe-7cae-bc3f-0f55-dd21f1fd449b</id>
<summary type="html"><![CDATA[Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market]]></summary>
<updated>2021-08-13T05:41:48+00:00</updated>
</entry>
<entry>
<title>The gene therapy market is projected to be worth USD 14.6 billion in 2030,  claims Roots Analysis</title>
<link href="https://news.prbase.org/@jameshebrew/the-gene-therapy-market-is-projected-to-be-worth-usd-146-billion-in-2030-claims-roots-analysis-6xwqwap38qj8"></link>
<id>urn:uuid:ef3e6813-5861-3291-e52d-d4def360a8ec</id>
<summary type="html"><![CDATA[Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing.]]></summary>
<updated>2021-08-03T09:39:06+00:00</updated>
</entry>
<entry>
<title>Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, claims Roots Analysis</title>
<link href="https://news.prbase.org/@jameshebrew/human-microbiome-based-products-market-is-projected-to-be-worth-usd-4-billion-by-2030-claims-roots-analysis-mp3q3r5p57ne"></link>
<id>urn:uuid:23227712-3de3-7dfb-30f1-2c8119b9d10b</id>
<summary type="html"><![CDATA[Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future]]></summary>
<updated>2021-08-03T09:33:54+00:00</updated>
</entry>
</feed>